Immunohistochemical demonstration of the expression of CYP2E1 in human breast tumour and non-tumour tissues

被引:31
作者
Kapucuoglu, N
Coban, T
Raunio, H
Pelkonen, O
Edwards, RJ
Boobis, AR
Iscan, M [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Toxicol, TR-06100 Ankara, Turkey
[2] Demetevler Oncol Hosp, Dept Pathol, TR-06100 Ankara, Turkey
[3] Oulu Univ, Dept Pharmacol & Toxicol, Oulu, Finland
[4] Univ London Imperial Coll Sci Technol & Med, Fac Med, Clin Pharmacol Sect, London, England
关键词
breast tumour; cytochrome P4502E1; immunohistochemistry; estrogen receptor status; menopausal status;
D O I
10.1016/S0304-3835(03)00277-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Environmental chemicals are one of the risk factors in breast cancer genesis. Cytochrome P450 2E1 (CYP2E1), a member of multigene superfamily of enzymes, plays a major role in the activation of some of these chemicals such as tobacco-derived N-nitrosamines. Using immunohistochemistry, the cellular distribution and the level of expression of CYP2E1 was assessed in breast turnour and surrounding tumour free (control) breast tissue in 25 pairs of samples obtained from females with infiltrating ductal carcinoma. Cells staining with the CYP2E1 antibody showed only cytoplasmic positivity with varying intensities in 100% (25/25) of tumours and 96% (24/25) of normal breast tissues. Cytoplasmic staining was present in invasive ductal carcinoma cells but not in turnour stroma. CYP2E1 was detected in normal epithelial, myoepithelial and to a lesser degree in some of the non-epithelial cells (e.g. endothelial cells). No positive staining was detected in other non-epithelial cells such as fibroblasts in normal breast tissues. When CYP2E1 staining was assessed semiquantitatively the mean staining score values of CYP2E1 was found to be significantly higher in tumours compared to that of normal breast tissues. These results show that CYP2E1 protein is expressed in both tumour and normal breast tissue with an increased expression in breast tumours. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 31 条
[11]   The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue [J].
Iscan, M ;
Klaavuniemi, T ;
Çoban, T ;
Kapucuoglu, N ;
Pelkonen, O ;
Raunio, H .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 70 (01) :47-54
[12]  
Larsen MC, 1998, CANCER RES, V58, P2366
[13]   Cytochrome P-4502E1: Its physiological and pathological role [J].
Lieber, CS .
PHYSIOLOGICAL REVIEWS, 1997, 77 (02) :517-544
[14]   BENZENE, AN EXPERIMENTAL MULTIPOTENTIAL CARCINOGEN - RESULTS OF THE LONG-TERM BIOASSAYS PERFORMED AT THE BOLOGNA INSTITUTE OF ONCOLOGY [J].
MALTONI, C ;
CILIBERTI, A ;
COTTI, G ;
CONTI, B ;
BELPOGGI, F .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1989, 82 :109-124
[15]   Immunohistochemical localization of cytochrome P450CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1 [J].
McFadyen, MCE ;
Breeman, S ;
Payne, S ;
Stirk, C ;
Miller, ID ;
Melvin, WT ;
Murray, GI .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (11) :1457-1464
[16]   EXPRESSION OF CYTOCHROME-P450 CYP1B1 IN BREAST-CANCER [J].
MCKAY, JA ;
MELVIN, WT ;
AHSEE, AK ;
EWEN, SWB ;
GREENLEE, WF ;
MARCUS, CB ;
BURKE, MD ;
MURRAY, GI .
FEBS LETTERS, 1995, 374 (02) :270-272
[17]   THE ROLE OF AROMATIC-HYDROCARBONS IN THE GENESIS OF BREAST-CANCER [J].
MORRIS, JJ ;
SEIFTER, E .
MEDICAL HYPOTHESES, 1992, 38 (03) :177-184
[18]   EXPRESSION OF XENOBIOTIC METABOLIZING ENZYMES IN BREAST-CANCER [J].
MURRAY, GI ;
WEAVER, RJ ;
PATERSON, PJ ;
EWEN, SWB ;
MELVIN, WT ;
BURKE, MD .
JOURNAL OF PATHOLOGY, 1993, 169 (03) :347-353
[19]  
Murray GI, 1997, CANCER RES, V57, P3026
[20]   ROLE OF GENETICS AND DRUG-METABOLISM IN HUMAN CANCER RISK [J].
NEBERT, DW .
MUTATION RESEARCH, 1991, 247 (02) :267-281